…patient reported outcome (PRO) measure for your clinical study Dr Keith Meadows, DHP Research & Consultancy Ltd.

Slides:

Advertisements

Similar presentations

Implementing the Stroke Palliative Approach Pathway

Advertisements

1 of 17 Information Strategy The Features of an Information Strategy © FAO 2005 IMARK Investing in Information for Development Information Strategy The.

Labeling claims for patient- reported outcomes (A regulatory perspective) FDA/Industry Workshop Washington, DC September 16, 2005 Lisa A. Kammerman, Ph.D.

Gender Perspectives in Tariffs (Pricing Policy) Gender Module #5 ITU Workshops on Sustainability in Telecommunication Through Gender & Social Equality.

Mixed methods synthesis ESRC Methods Festival 2006 James Thomas Institute of Education, University of London.

School Based Assessment and Reporting Unit Curriculum Directorate

P romoting A ction on R esearch I mplementation in H ealth S ervices Promoting Action on Research Implementation in Health Services Project Team Jo Rycroft-Malone.

Introduction to Competency-Based Residency Education

Interpreting of Patient-Reported Outcomes

Evidence Based Advertising “Don’t accept your dog’s admiration as conclusive evidence that you are wonderful” -Ann Landers.

Group Report C is for CLASS. Overall plan – teaching module on Community Orientation 1 to 1 teaching process in practice Both student and trainee teaching.

1 Epoetin Alpha: FDA Overview of Patient Reported Outcome (PRO) Claims Ann Marie Trentacosti, M.D. Study Endpoints and Labeling Office of New Drugs Food.

The situation The requirements The benefits What’s needed to make it work How to move forward.

Consistency of Assessment

The ICH E5 Question and Answer Document Status and Content Robert T. O’Neill, Ph.D. Director, Office of Biostatistics, CDER, FDA Presented at the 4th Kitasato-Harvard.

Comprehensive Curriculum Framework for Tiered Instruction: A Response to Intervention Model Sarah Jackson, M.Ed. Sandra Hess Robbins, M.Ed. Sanna Harjusola-Webb,

EEN [Canada] Forum Shelley Borys Director, Evaluation September 30, 2010 Developing Evaluation Capacity.

CEET Conference 2008 Is Quality Assurance Improving? Rob Fearnside, Deputy Director VRQA.

North East of England MAGIC Team Making Good Decisions in Collaboration 3 hour V Shared Decision Making Extended Skills Training Workshop.

WRITING A RESEARCH PROPOSAL

Good Customer Service Needs Good People Management.

Welcome ISO9001:2000 Foundation Workshop.

MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH Brendan Mulhern 1, Keith Meadows 2, Donna.

Triple C Competency-based Curriculum: Implications for Family Medicine Residency Programs.

Administrator Checklist Research and Training Center on Service Coordination.

InterRAI Preliminary Screener for Primary Care and Community Care Settings (interRAI Preliminary Screener) Training Intent: Welcome participants & introduce.

From Conformance to Performance: Using Integrated Risk Management to achieve Organisational Health Ms Stacie Hall Comcover National Manager.

Dr Keith Meadows, DHP Research & Consultancy Ltd.

ORIENTATION SESSION Strengthening Chronic Disease Prevention & Management.

Professional Certificate – Managing Public Accounts Committees Ian “Ren” Rennie.

CHALLENGES FOR PRAGMATIC TRIALS IN EUROPE Donna A. Messner, PhD.

FDA Approach to Review of Outcome Measures for Drug Approval and Labeling: Content Validity Initiative on Methods, Measurement, and Pain Assessment in.

The Audit Process Tahera Chaudry March Clinical audit A quality improvement process that seeks to improve patient care and outcomes through systematic.

CArers of people with Dementia: Empowerment and Efficacy via Education (CAD: E 3 ) A multi-disciplinary study of the impact of educational interventions.

Thomas College Name Major Expected date of graduation address

Unit 1 – Preparation for Assessment LO 1.1&1.2&1.3.

Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.

The Practical Art of Endpoint Selection: Industry Perspectives A View from the Pharma Industry of the FDA Guidance on PROs Glenn A. Phillips, Ph.D. Director.

OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,

Shared Decision Making MAGIC — Making Good decisions In Collaboration — Shared decision making the norm — Multi-centre, large scale implementation programme.

Assessing the influence on processes when evolving the software architecture By Larsson S, Wall A, Wallin P Parul Patel.

Programme Objectives Analyze the main components of a competency-based qualification system (e.g., Singapore Workforce Skills) Analyze the process and.

OLGA: A nice niche designed to meet your evolving needs Pennifer Erickson, Ph.D. Presented at the Spring meeting of the Special Library Association’s Pharmaceutical.

Advice on Data Used to Measure Outcomes Friday 20 th March 2009.

Access to HE Standardisation Event Add title of the event e.g. Health Date and time.

1 Qualitative Research: Challenges and Opportunities Presented by: Anne Smyth Liz Dimitriadis.

4 Countries Project: Modernising Learning Disability Nursing Dr Ben Thomas Director of Mental Health & Learning Disability Nursing 16 December, 2011.

Evaluation: from Objectives to Outcomes Janet Myers, PhD MPH AIDS Education and Training Centers National Evaluation Center

Quality of Life (QOL) & Patient Reported Outcomes (PRO) Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research Group, DCP, NCI, NIH,

Ergonomics Risk Management: Strategies and Interventions at Workplace Level Back to Basics Conference June 13 th 2014 Frank Power Inspector (Projects Manager)

Session: Instructional methods; How to prepare practical exercise/case study 24 th January 2013 Dr. Eliona Kulluri Bimbashi (University of Tirana)

MRCGP The Clinical Skills Assessment January 2013.

SUPPORTING PEOPLE PROVIDER FORUMS An overview of Supporting People’s new approach to Performance Monitoring and Quality Assurance.

The AMUsE Model: A Strategy to Assess Attitudes, Motivation, Utility and self-Efficacy in Interprofessional Team Training.

Health Education Grades 6, 7, 8, and 9 Healthy Learners = Better Learners Better Learners = Healthy Learners.

Organizations of all types and sizes face a range of risks that can affect the achievement of their objectives. Organization's activities Strategic initiatives.

Middle Managers Workshop 2: Measuring Progress. An opportunity for middle managers… Two linked workshops exploring what it means to implement the Act.

The Holistic Approach to the Design and Meaningful Use of Electronic Health Records: A Nursing Experience Frances Beadle, MSc Health Informatics Nurse.

Dr. Sabine Brookman-May, MD, PhD Regional Therapeutic Area Expert Oncology (Europe, Middle East, Africa) - Janssen R&D Improving patients involvement in.

Andy Passey September 23rd 2003 Advanced Wound Management in Europe: Market Overview and Critical Success Factors © 2003 Frost & Sullivan. All rights reserved.

CoRPS London 26 & 27 October 2010 Center of Research on Psychology in Somatic diseases Understanding PRO in hematological disorders: Do we have a consensus?

Session 4: Planning Lessons Tuesday 12th October 2010

Clinical Studies Continuum

An Acute Problem? NCEPOD.

Progress Report on the Patient Reported Outcomes Harmonization Team

Style You need to demonstrate knowledge and understanding beyond undergraduate level and should also reach a level of scope and depth beyond that taught.

Patient Involvement in the Development and Use of Safe Medicines Introductory Section – Concepts to Consider CIOMS XI WG Second Meeting October 23-24,

Regulatory Perspective of the Use of EHRs in RCTs

How inclusive is my module... and yours?

Presentation transcript:

…patient reported outcome (PRO) measure for your clinical study Dr Keith Meadows, DHP Research & Consultancy Ltd

Both nationally and internationally, the assessment of outcomes based on the patient’s perspective using patient-reported outcome (PRO) measures, are increasingly accompanying the traditional clinical ways of measuring health and the effects of treatment on the patient. Data derived from PROs provides added value in supporting key biomedical endpoints, reimbursement, product differentiation and marketing. However, many questions remain such as what is achievable using a PRO? How can we distinguish between the different measured endpoints? How can we understand a PRO score in relation to clinical endpoints? And most importantly, how do we get key stakeholders to pay for their inclusion in clinical trials and observational studies? DHP Research & Consultancy provides both bespoke and standard one-day workshops aimed at addressing these issues and helping your outcomes team make sound decisions regarding the concepts, strategies and instruments for capturing PRO data in clinical trials and observational studies.

Understand what PROs are, what they measure and what is achievable using PRO endpoints for your labelling claim Distinguish between the different endpoints measured by PROs e.g. QoL health status and the importance of matching the concept with the claim Recognise the benefits of understanding the patients’ perspective to you and the patient in the evaluation of treatment outcomes Have a deeper insight into the key concepts and strategies for selecting an appropriate PRO for your clinical trial or observational study Demonstrate the benefits of patient-perceived effects as a valuable adjunct to indicators of medical efficacy in clinical trials and observational studies Our workshop equips you with key insights into required concepts, strategies and instruments for capturing PRO data.

As an introduction to PROs we provide a comprehensive overview of the benefits to you and the patient by understanding the perspective of the patient and how this can be achieved using PROs. PROs are often selected on the basis of their popularity. To ensure your data is not misinterpreted and conclusions flawed through inappropriate selection, we help you to distinguish between the different PRO endpoints e.g. does the EQ-5D and SF-36 measure QoL? In addition to examining the different types of PRO - including, generic and disease-specific - we also explore ways to increase the sensitivity of PROs in clinical studies and aid interpretation of the relationships between clinical endpoints and PRO scores. With emphasis on the importance of linking the concept with the claim, we examine what is achievable with PROs as well as focusing on different approaches - including the development of endpoint models - to enable you to identify key PRO concepts to demonstrate potential treatment effects. Ensuring a strong link between the item content of the PRO, its measured concept and study objectives is essential for identifying potential treatment benefits. We explore evidence-based approaches to help you select an appropriate PRO by evaluating its developmental history including, examination of content validity and other properties of the instrument. Stakeholders with an interest in PRO outcomes has over the past years broadened to include, regulators, health technology assessment authorities, policy makers and physicians. Nevertheless, demonstration of the cost/benefits for inclusion of PROs in clinical trials and observational studies can be challenging. Through interactive sessions, we explore how the benefits of potential patient-perceived effects can be shown as a valuable adjunct to indicators of medical efficacy in clinical trials and observational studies. Concepts: Identifying key concepts: Selecting the appropriate PRO: Key stakeholders: The patient’s perspective: An overview of our PRO workshop

An interactive training session Review of key principles and concepts Comprehensive take away training pack Opportunities for discussion and debate Follow-up training To help you identify the appropriate PRO to demonstrate potential treatment benefits We will review any particular issues that have arisen as you embed PROs into your research A bibliography of further reading material A detailed guide to selecting PROs Detailed workshop notes What is included in our PRO workshop?